# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 25: Amendment of Schedule 7 (standard provisions for manufacturing authorisations)


In Part 1 of Schedule 7, in the definition of “product specification”, omit “or any equivalent provisions in any EEA State other than the United Kingdom”.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/25 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-25
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.